Camden Capital »

Corcept Therapeutics Incorporated shares owned by Camden Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Camden Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $601k 7.2k 83.11
2025-03-31 $295k 2.6k 114.22
2024-12-31 $204k 4.1k 50.39
2022-03-31 $210k 9.3k 22.48
2021-06-30 $204k 9.3k 21.95
2020-12-31 $207k 7.9k 26.15

More positions owned by Camden Capital

NVIDIA Corporation Put Option (NVDA)
Onemain Holdings (OMF)
Citigroup Com New (C)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Flagstar Financial Com New (FLG)
PNC Financial Services (PNC)

View all positions for Camden Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated